AXIOS PRO Exclusive: HyperSpectral bags $9M for pathogen testing

6.6.2024

Pathogen detection startup HyperSpectral raised an $8.5 million Series A led by RRE Ventures and Kibo Ventures, CEO Matt Theurer tells Axios exclusively.

>> NEWSLETTER

Get updates and insight direct to your inbox.

Thanks for subscribing.

Oops! Something went wrong while submitting the form.

We never share your data with third parties.

AXIOS PRO Exclusive: HyperSpectral bags $9M for pathogen testing

Get updates and insight direct to your inbox.

Pages